Login / Signup

Impact of fibrates on circulating cystatin C levels: a systematic review and meta-analysis of clinical trials.

Amir Hossein SahebkarLuis E Simental-MendíaMatteo PirroFabrizio MontecuccoFederico CarboneMaciej BanachGeorge E BarretoAlexandra E Butler
Published in: Annals of medicine (2018)
The results suggest that fenofibrate treatment adversely affects cystatin C levels and might partially explain the limited efficacy of fenofibrate in reducing cardiovascular events. Key message Fenofibrate treatment adversely affects cystatin C levels and might partially explain the limited efficacy of fenofibrate in reducing cardiovascular events.
Keyphrases
  • cardiovascular events
  • coronary artery disease
  • cardiovascular disease
  • clinical trial
  • type diabetes
  • replacement therapy
  • open label